Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Immunological Methods
|
July 15, 2015
A microarray-based reaction rate analysis platform. Is there evidence of validity?
Magdalena Godzwon, Mattias Levin, Anna Säll, et al.
Plos One
|
February 14, 2018
Advancing the immunoaffinity platform AFFIRM to targeted measurements of proteins in serum in the pg/ml range
Anna Säll, Daniel Corbee, Sara Vikström, et al.
New Biotechnology
|
December 26, 2015
Advancing the global proteome survey platform by using an oriented single chain antibody fragment immobilization approach
Anna Säll, Helena Persson, Mats Ohlin, et al.
Journal of Proteome Research
|
October 10, 2015
Development of Phage-Based Antibody Fragment Reagents for Affinity Enrichment of Bacterial Immunoglobulin G Binding Proteins
Anna Säll, Kristoffer Sjöholm, Sofia Waldemarson, et al.
Journal of Proteome Research
|
October 23, 2014
AFFIRM--a multiplexed immunoaffinity platform that combines recombinant antibody fragments and LC-SRM analysis
Anna Säll, Fredrika Carlsson, Niclas Olsson, et al.
New Biotechnology
|
August 6, 2017
Combination of phage and Gram-positive bacterial display of human antibody repertoires enables isolation of functional high affinity binders
Francis Jingxin Hu, Anna-Luisa Volk, Helena Persson, et al.
Mabs
|
March 26, 2024
RUBY® - a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties
Barnabas Nyesiga, Mattias Levin, Anna Säll, et al.
Protein Engineering, Design & Selection : PEDS
|
September 4, 2016
Generation and analyses of human synthetic antibody libraries and their application for protein microarrays
Anna Säll, Maria Walle, Christer Wingren, et al.
International Journal of Proteomics
|
November 21, 2015
A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma
Anna S Gerdtsson, Núria Malats, Anna Säll, et al.
Cancer Immunology, Immunotherapy : CII
|
October 5, 2023
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
Karin Enell Smith, Sara Fritzell, Anneli Nilsson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Immunological Methods
|
July 15, 2015
A microarray-based reaction rate analysis platform. Is there evidence of validity?
Magdalena Godzwon, Mattias Levin, Anna Säll, et al.
Plos One
|
February 14, 2018
Advancing the immunoaffinity platform AFFIRM to targeted measurements of proteins in serum in the pg/ml range
Anna Säll, Daniel Corbee, Sara Vikström, et al.
New Biotechnology
|
December 26, 2015
Advancing the global proteome survey platform by using an oriented single chain antibody fragment immobilization approach
Anna Säll, Helena Persson, Mats Ohlin, et al.
Journal of Proteome Research
|
October 10, 2015
Development of Phage-Based Antibody Fragment Reagents for Affinity Enrichment of Bacterial Immunoglobulin G Binding Proteins
Anna Säll, Kristoffer Sjöholm, Sofia Waldemarson, et al.
Journal of Proteome Research
|
October 23, 2014
AFFIRM--a multiplexed immunoaffinity platform that combines recombinant antibody fragments and LC-SRM analysis
Anna Säll, Fredrika Carlsson, Niclas Olsson, et al.
New Biotechnology
|
August 6, 2017
Combination of phage and Gram-positive bacterial display of human antibody repertoires enables isolation of functional high affinity binders
Francis Jingxin Hu, Anna-Luisa Volk, Helena Persson, et al.
Mabs
|
March 26, 2024
RUBY® - a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties
Barnabas Nyesiga, Mattias Levin, Anna Säll, et al.
Protein Engineering, Design & Selection : PEDS
|
September 4, 2016
Generation and analyses of human synthetic antibody libraries and their application for protein microarrays
Anna Säll, Maria Walle, Christer Wingren, et al.
International Journal of Proteomics
|
November 21, 2015
A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma
Anna S Gerdtsson, Núria Malats, Anna Säll, et al.
Cancer Immunology, Immunotherapy : CII
|
October 5, 2023
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
Karin Enell Smith, Sara Fritzell, Anneli Nilsson, et al.
Page
of 2